Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NOV Inc. Common Stock (NOV) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

NOV Inc. Common StockTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

NOV Inc. Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? NOV Inc. Common Stock trades at $18.75 (market cap $6.76B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is the larger of the two by market cap, and NOV Inc. Common Stock pays the higher dividend (1.9%). Which is the better fit depends on your goals — on Pluang, investors hold NOV Inc. Common Stock for 6 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

NOVRDY
Market Cap
$6.76B$10.78B
Volume
2,412,5542,724,343
Sector
EnergyHealth
52-Week High
$21.71$15.38
52-Week Low
$12.66$11.38
Typical Hold Time
6 Days0 Days
Enterprise Value
$7.92B$10.68B
Dividend Yield
1.9%0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NOV Inc. Common Stock

NOV trades at $18.96, up 0.37% with a bearish technical signal from moving averages. The company reported mixed Q2 2026 results, beating EPS estimates but showing revenue decline. Valuation metrics show a high P/E ratio of 70.22 but attractive P/S of 0.81, while profitability remains weak with 1.1% net margin. Recent news highlights strong subsea demand but Middle East risks and weak equipment sales.

The outlook is cautious with analyst consensus at $21.80 target (15% upside) but technical weakness. Investment opportunity lies in energy equipment strength and margin improvements, while risks include geopolitical exposure, competitive pressures, and inconsistent earnings performance. The stock faces headwinds from capital spending constraints in the oilfield sector.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NOV

No sentiment data available yet.

RDY
100% Buy0% Sell
Avg holding period · 0 Days

About NOV Inc. Common Stock

NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.

Read more on NOV →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →